ArticleTuberculosis and respiratory diseases2013
Endobronchial metastases from extrathoracic malignancies: recent 10 years' experience in a single university hospital.
Article in Tuberculosis and respiratory diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 25 citations in OpenAlex.
- Endobronchial Metastasis with Extension to the Left Atrium from Adenocarcinoma of Gastric 3 Years after Total Gastrectomy.Sultan Qaboos University medical journal · 2025Article
- Isolated Endobronchial Metastasis of Breast Cancer Successfully Managed With Multimodal Treatment.Cureus · 2023Article
- A case of endobronchial metastasis of colon cancer mimics sarcoidosis, and a review of related literature.Journal of cancer research and clinical oncology · 2023Review
- Case report: Hilar metastasis of breast cancer: A single-center retrospective case-control study.Frontiers in surgery · 2023Article
- [Investigation and Analysis of Primary Lung Cancer with Endotracheal and Endobronchial Metastases].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020Article
- A case of an endobronchial metastasis from an endometrial carcinoma.SAGE open medical case reports · 2019Article
- Secondary tracheal tumors: a systematic review.Annals of cardiothoracic surgery · 2018Review
- Article
- Liquid-based cytological test of samples obtained by catheter aspiration is applicable for the bronchoscopic confirmation of pulmonary malignant tumors.International journal of clinical and experimental pathology · 2014Article
- Endobronchial metastasis from resected renal cell carcinoma causing total lung collapse.Respirology case reports · 2013Article
- Endobronchial Metastasis of Renal Cancer Presented as Atelectasis.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough the lung is a common site of metastasis, endobronchial metastases (EBM) from extrathoracic malignancies are rare. Previous studies were retrospective reviews of the cases from each single institute, and the last one was performed between 1992 and 2002. We evaluated the characteristics of patients with EBM who had been diagnosed in recent 10 years in our hospital.
methodsWe retrospectively reviewed 1,275 patients who had undergone diagnostic bronchoscopic procedures between 2001 and 2011. An EBM was defined as bronchoscopically notable lesion, which was histopathologically identical to the primary tumor.
resultsA total of 18 cases of EBM were identified. The mean age was 53 years, and 12 cases of the 18 patients were female. The most common primary malignancies were colorectal cancer and breast cancer (4 cases each), followed by cervix cancer (3 cases) and renal cell carcinoma (2 cases). Cough was the most common symptom. The most common radiologic finding was atelectasis, which was identified in 27.7% of the cases. The median interval from the diagnosis of primary malignancy to the diagnosis of EBM was 14 months (range, 0-112 months). The median survival time from the diagnosis of EBM was 10 months (range, 1-39 months).
conclusionEBM from extrathoracic malignancies were rare. Colorectal cancer and breast cancer were common as primary malignancies. Fiberoptic bronchoscopy should be performed in all patients, who are suspected of having EBM. If atypical clinical and pathological features are present, appropriate diagnostic studies should be undertaken.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.